Literature DB >> 6421723

Differential tissue distribution and ontogeny of DC-1 and HLA-DR antigens.

P G Natali, O Segatto, S Ferrone, R Tosi, G Corte.   

Abstract

The tissue distribution and the ontogeny of DC-1 antigens have been investigated and compared with those of HLA-DR antigens. Indirect immunofluorescence (IIF) staining of surgically removed normal tissues from adults with the monoclonal antibody (MoAb) BT3.4 has detected DC-1 antigens in tissues of various embryologic origin. The tissue distribution of DC-1 antigens is more restricted than that of HLA-DR antigens, as the former are not detected in duodenal epithelium, colon mucosa, and ductal mammary gland epithelium. In fetuses up to 26 weeks of age, DC-1 antigens were detected only on cortical and medullary thymic dendritic cells with an anatomic distribution similar to that of reticuloepithelial cells and in endothelial cells of the small intestine. At this stage of intrauterine life, HLA-DR antigens have already reached their full tissue distribution. The tissue distribution and the ontogeny of DC-1 antigens resemble those of their murine counterparts, i.e., the I-A antigens.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6421723     DOI： 10.1007/bf00387853

Source DB:  PubMed          Journal:  Immunogenetics        ISSN： 0093-7711            Impact factor:   2.846


  27 in total

1.  Serologic and immunochemical characterization of the specificity of four monoclonal antibodies to distinct antigenic determinants expressed on subpopulations of human Ia-like antigens.

Authors:  V Quaranta; M A Pellegrino; S Ferrone
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

2.  Protein A, avidin, and biotin in immunohistochemistry.

Authors:  S M Hsu; L Raine
Journal:  J Histochem Cytochem       Date:  1981-11       Impact factor: 2.479

3.  Ontogeny of human Ia antigens.

Authors:  P G Natali; C Russo; A K Ng; M R Nicotra; C Apollonj; M A Pellegrino; S Ferrone
Journal:  Cell Immunol       Date:  1982-11-01       Impact factor: 4.868

4.  Ia-like antigens on freshly explanted human melanoma.

Authors:  P G Natali; P Cordiali-Fei; R Cavaliere; F Di Filippo; V Quaranta; M A Pellegrino; S Ferrone
Journal:  Clin Immunol Immunopathol       Date:  1981-05

5.  Effect of polyclonal and monoclonal HLA-DR xenoantibodies on xenogeneic mixed lymphocyte reactions.

Authors:  C Russo; V Quaranta; F Indiveri; M A Pellegrino; S Ferrone
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

6.  A monoclonal antibody reactive with human peripheral blood monocytes.

Authors:  J Breard; E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

7.  Expression of Ia-like antigens in normal human nonlymphoid tissues.

Authors:  P G Natali; C De Martino; V Quaranta; M R Nicotra; F Frezza; M A Pellegrino; S Ferrone
Journal:  Transplantation       Date:  1981-01       Impact factor: 4.939

8.  Three Ia species with different structures and alloantigenic determinants in an HLA-homozygous cell line.

Authors:  N Tanigaki; R Tosi; R J Duquesnoy; G B Ferrara
Journal:  J Exp Med       Date:  1983-01-01       Impact factor: 14.307

9.  Ia-bearing T lymphocytes in man. Their identification and role in the generation of allogeneic helper activity.

Authors:  S M Fu; N Chiorazzi; C Y Wang; G Montrazeri; H G Kunkel; H S Ko; A B Gottlieb
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

10.  DR (Ia-like) antigens on human melanoma cells. Serological detection and immunochemical characterization.

Authors:  B S Wilson; F Indiveri; M A Pellegrino; S Ferrone
Journal:  J Exp Med       Date:  1979-03-01       Impact factor: 14.307
View more
  19 in total

Review 1.  Ontogeny of the human thymus during fetal development.

Authors:  D F Lobach; B F Haynes
Journal:  J Clin Immunol       Date:  1987-03       Impact factor: 8.317

2.  Haemopoiesis in human fetal and embryonic liver. Immunohistochemical determination in B5-fixed paraffin-embedded tissues.

Authors:  W Timens; W A Kamps; T Rozeboom-Uiterwijk; S Poppema
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

Review 3.  HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance.

Authors:  Barbara Seliger; Matthias Kloor; Soldano Ferrone
Journal:  Oncoimmunology       Date:  2017-02-06       Impact factor: 8.110

4.  The expression of class II MHC gene products by fallopian tube epithelium in pregnancy and throughout the menstrual cycle.

Authors:  J N Bulmer; U Earl
Journal:  Immunology       Date:  1987-06       Impact factor: 7.397

5.  Class II antigen (HLA-DR) expression by intestinal epithelial cells in inflammatory diseases of colon.

Authors:  G B McDonald; D P Jewell
Journal:  J Clin Pathol       Date:  1987-03       Impact factor: 3.411

6.  HLA-A,B,C, HLA-D/DR and HLA-D/DQ expression on unfixed liver biopsy sections from patients with chronic liver disease.

Authors:  G Ballardini; F B Bianchi; R Mirakian; M Fallani; E Pisi; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

7.  HLA-DR, DP and DQ expression in the small intestine of patients with coeliac disease.

Authors:  N J Marley; J C Macartney; P J Ciclitira
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

8.  Immunohistological characterization of the decidual leucocytic infiltrate related to endometrial gland epithelium in early human pregnancy.

Authors:  J N Bulmer; P M Johnson
Journal:  Immunology       Date:  1985-05       Impact factor: 7.397

9.  Sheep lymphocyte antigens (OLA). II. Major histocompatibility complex class II molecules.

Authors:  N K Puri; C R Mackay; M R Brandon
Journal:  Immunology       Date:  1985-12       Impact factor: 7.397

10.  Thymoma epithelial cells secrete thymic hormone but do not express class II antigens of the major histocompatibility complex.

Authors:  W Savino; G Manganella; J M Verley; A Wolff; S Berrih; P Levasseur; J P Binet; M Dardenne; J F Bach
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.